Is It Worthy of Switching to PegIFN Alfa-2a in Patients Achieving Virological Suppression With Entecavir?
Journal of Hepatology - Netherlands
doi 10.1016/j.jhep.2015.01.041
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2015
Authors
Publisher
Elsevier BV